2 results match your criteria: "Osaka University Medical School E7[Affiliation]"
Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma.
Arch Ophthalmol
July 2008
Department of Ophthalmology, Osaka University Medical School E7, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Repeated intravitreal triamcinolone injections in Behçet disease that is resistant to conventional therapy: one-year results.
Am J Ophthalmol
January 2006
Department of Ophthalmology, Osaka University Medical School E7, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Purpose: To determine whether repeated intravitreal triamcinolone (IVTA) injections in patients with Behçet disease that is resistant to conventional therapy will prevent recurrences of uveitis.
Design: Prospective preliminary clinical trial.
Methods: Nine eyes of five patients with Behçet disease with sight-threatening uveitis that was resistant to conventional therapy received repeated IVTA injections.